AT&T Inc. vs Twist Bioscience Corp — how do they compare? AT&T Inc. trades at $22.3 (market cap $152.52B), while Twist Bioscience Corp trades at $88.31 (market cap $5.45B). The key difference: AT&T Inc. is far larger — about 28× Twist Bioscience Corp's market cap, and AT&T Inc. pays a 5.06% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| T | TWST | |
|---|---|---|
Market Cap | $152.52B | $5.45B |
Sector | Media | Health |
52-Week High | $29.62 | $102.88 |
52-Week Low | $20.49 | $24.16 |
Enterprise Value | $297.87B | $5.37B |
Dividend Yield | 5.06% | — |
Trailing returns across standard periods
Latest headlines on both assets
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →